Cargando…

Mathematical models for biomarker calculation of drug-induced liver injury in humans and experimental models based on gadoxetate enhanced magnetic resonance imaging

BACKGROUND: Drug induced liver injury (DILI) is a major concern when developing new drugs. A promising biomarker for DILI is the hepatic uptake rate of the contrast agent gadoxetate. This rate can be estimated using a novel approach combining magnetic resonance imaging and mathematical modeling. How...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karlsson, Markus, Simonsson, Christian, Dahlström, Nils, Cedersund, Gunnar, Lundberg, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821424/ https://www.ncbi.nlm.nih.gov/pubmed/36608050 http://dx.doi.org/10.1371/journal.pone.0279168

Ejemplares similares

Model-inferred mechanisms of liver function from magnetic resonance imaging data: Validation and variation across a clinically relevant cohort
por: Forsgren, Mikael F., et al.
Publicado: (2019)

Physiologically Realistic and Validated Mathematical Liver Model Revels Hepatobiliary Transfer Rates for Gd-EOB-DTPA Using Human DCE-MRI Data
por: Forsgren, Mikael Fredrik, et al.
Publicado: (2014)

Mechanisms of a Sustained Anti‐inflammatory Drug Response in Alveolar Macrophages Unraveled with Mathematical Modeling
por: Nyman, Elin, et al.
Publicado: (2020)

Gadoxetic acid magnetic-enhanced resonance imaging in the diagnosis of cholangiocarcinoma
por: Inchingolo, Riccardo, et al.
Publicado: (2020)

Gadoxetic acid-enhanced magnetic resonance imaging: Hepatocellular carcinoma and mimickers
por: Kim, Yeun-Yoon, et al.
Publicado: (2019)

Physiologically Based Pharmacokinetic Modeling of Transporter-Mediated Hepatic Disposition of Imaging Biomarker Gadoxetate in Rats
por: Scotcher, Daniel, et al.
Publicado: (2021)

Digital twin predicting diet response before and after long-term fasting
por: Silfvergren, Oscar, et al.
Publicado: (2022)

Diagnosis of Cholecysto-Colonic Fistula Using Gadoxetic Acid – Magnetic Resonance Cholangiography
por: Mourri, A. B., et al.
Publicado: (2015)

Differentiating Focal Eosinophilic Infiltration from Metastasis in the Liver with Gadoxetic Acid-Enhanced Magnetic Resonance Imaging
por: Lee, Mi Hee, et al.
Publicado: (2011)

Magnetic resonance imaging of liver tumors using gadoxetic acid (Gd-EOB-DTPA) - pilot study
por: Borusewicz, Pola, et al.
Publicado: (2019)

Mechanistic Mathematical Modeling Tests Hypotheses of the Neurovascular Coupling in fMRI
por: Lundengård, Karin, et al.
Publicado: (2016)

Indeterminate liver lesions on gadoxetic acid-enhanced magnetic resonance imaging of the liver: Case-based radiologic-pathologic review
por: Noreikaite, Jurate, et al.
Publicado: (2021)

Gadoxetic acid-enhanced magnetic resonance imaging significantly influences the clinical course in patients with colorectal liver metastases
por: Sibinga Mulder, B. G., et al.
Publicado: (2018)

Role of gadoxetic acid-enhanced liver magnetic resonance imaging in the evaluation of hepatocellular carcinoma after locoregional treatment
por: Gatti, Marco, et al.
Publicado: (2022)

A radiomics model based on preoperative gadoxetic acid–enhanced magnetic resonance imaging for predicting post-hepatectomy liver failure in patients with hepatocellular carcinoma
por: Li, Changfeng, et al.
Publicado: (2023)

The utility of gadoxetic acid-enhanced magnetic resonance imaging in the surveillance for postoperative recurrence of hepatocellular carcinoma
por: Kim, Jung Hee, et al.
Publicado: (2016)

Can gadoxetic acid–enhanced magnetic resonance imaging be used to avoid liver biopsy in patients with nonalcoholic fatty liver disease?
por: Amorim, Viviane Brandão, et al.
Publicado: (2020)

Meta-Analysis of Gadoxetic Acid Disodium (Gd-EOB-DTPA)-Enhanced Magnetic Resonance Imaging for the Detection of Liver Metastases
por: Chen, Lihua, et al.
Publicado: (2012)

Association between relative liver enhancement on gadoxetic acid enhanced magnetic resonance images and histologic grade of hepatocellular carcinoma
por: Jin, Young-Joo, et al.
Publicado: (2017)

A Case of Hyperintense Liver Metastases of Breast Cancer in the Hepatobiliary Phase on Gadoxetic Acid-Enhanced Magnetic Resonance Imaging
por: Yamaguchi, Tomoyuki, et al.
Publicado: (2020)

Primary hepatic neuroendocrine tumor: gadoxetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging
por: Baek, Soo-heui, et al.
Publicado: (2013)

Gadoxetic Acid Disodium-Enhanced Magnetic Resonance Imaging for the Detection of Hepatocellular Carcinoma: A Meta-Analysis
por: Liu, Xijiao, et al.
Publicado: (2013)

Gadoxetic acid-enhanced magnetic resonance imaging can predict the pathologic stage of solitary hepatocellular carcinoma
por: Chou, Yi-Chen, et al.
Publicado: (2019)

Optimization of hepatobiliary phase imaging in gadoxetic acid-enhanced magnetic resonance imaging: a narrative review
por: Wang, Chao, et al.
Publicado: (2023)

A multi-scale digital twin for adiposity-driven insulin resistance in humans: diet and drug effects
por: Herrgårdh, Tilda, et al.
Publicado: (2023)

Quantitative Assessment of Liver Function Using Gadoxetate-Enhanced Magnetic Resonance Imaging: Monitoring Transporter-Mediated Processes in Healthy Volunteers
por: Georgiou, Leonidas, et al.
Publicado: (2017)

Consensus report from the 9(th) International Forum for Liver Magnetic Resonance Imaging: applications of gadoxetic acid-enhanced imaging
por: Koh, Dow-Mu, et al.
Publicado: (2021)

Atypical Findings of Focal Nodular Hyperplasia with Gadoxetic Acid (Gd-EOB-DTPA)-Enhanced Magnetic Resonance Imaging
por: Yoon, Jung-Hee, et al.
Publicado: (2014)

Gadoxetic acid–enhanced magnetic resonance imaging to predict paritaprevir-induced hyperbilirubinemia during treatment of hepatitis C
por: Okubo, Hironao, et al.
Publicado: (2018)

The role of gadoxetic acid-enhanced magnetic resonance cholangiography in the evaluation of postoperative bile duct injury: pictorial essay
por: Ribeiro, Bruno Jucá, et al.
Publicado: (2019)

Ex vivo gadoxetate relaxivities in rat liver tissue and blood at five magnetic field strengths from 1.41 to 7 T
por: Ziemian, Sabina, et al.
Publicado: (2020)

Nonlinear mixed-effects modelling for single cell estimation: when, why, and how to use it
por: Karlsson, Markus, et al.
Publicado: (2015)

Radiomics model based on preoperative gadoxetic acid-enhanced MRI for predicting liver failure
por: Zhu, Wang-Shu, et al.
Publicado: (2020)

Cost evaluation of gadoxetic acid-enhanced magnetic resonance imaging in the diagnosis of colorectal-cancer metastasis in the liver: Results from the VALUE Trial
por: Zech, Christoph J., et al.
Publicado: (2016)

Diagnostic performance of abbreviated gadoxetic acid-enhanced magnetic resonance protocols with contrast-enhanced computed tomography for detection of colorectal liver metastases
por: Ozaki, Kumi, et al.
Publicado: (2022)

Combining test statistics and models in bootstrapped model rejection: it is a balancing act
por: Johansson, Rikard, et al.
Publicado: (2014)

Intracellular accumulation capacity of gadoxetate: initial results for a novel biomarker of liver function
por: Fahlenkamp, Ute Lina, et al.
Publicado: (2020)

Acute transient tachypnea following gadoxetate administration in a rhesus macaque during contrast-enhanced magnetic resonance imaging
por: Aiosa, Nina M., et al.
Publicado: (2019)

Pseudo-random Trajectory Scanning Suppresses Motion Artifacts on Gadoxetic Acid-enhanced Hepatobiliary-phase Magnetic Resonance Images
por: Nakamura, Yuko, et al.
Publicado: (2019)

Gadoxetic acid-enhanced magnetic resonance imaging predicts hyperbilirubinemia induced by glecaprevir during hepatitis C virus treatment
por: Okubo, Hironao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_aa4ktt9s87ifvpki23bpakuuu7